Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 39905-48-1 | MDL No. : | MFCD00457982 |
Formula : | C12H17NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SNTDJOBXSWWDSN-UHFFFAOYSA-N |
M.W : | 191.27 | Pubchem ID : | 3026822 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 59.26 |
TPSA : | 35.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.32 cm/s |
Log Po/w (iLOGP) : | 2.37 |
Log Po/w (XLOGP3) : | 3.02 |
Log Po/w (WLOGP) : | 2.99 |
Log Po/w (MLOGP) : | 2.28 |
Log Po/w (SILICOS-IT) : | 2.44 |
Consensus Log Po/w : | 2.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.11 |
Solubility : | 0.147 mg/ml ; 0.00077 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.43 |
Solubility : | 0.0718 mg/ml ; 0.000376 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.22 |
Solubility : | 0.116 mg/ml ; 0.000605 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.64 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
700 mg | With palladium 10% on activated carbon; hydrogen In methanol for 16 h; | A stirred solution of 1 -(cyclohexyloxy)-4-nitrobenzene (1 g) in MeOH (15 mL) was purged with nitrogen and 10percent Pd/C (0.721 g) was added. The reaction mixture was stirred for 16 ht under a hydrogen atmosphere (balloon). The reaction mixture was filtered through Celite and the filtrate was concentrated under reduced pressure to afford the titled compound (700 mg). LCMS m/z 192.1 (M+H)+. |
[ 917483-71-7 ]
4-(Tetrahydropyran-4-yloxy)aniline
Similarity: 0.93
[ 6245-50-7 ]
4,4'-(Butane-1,4-diylbis(oxy))dianiline
Similarity: 0.88
[ 917483-71-7 ]
4-(Tetrahydropyran-4-yloxy)aniline
Similarity: 0.93
[ 6245-50-7 ]
4,4'-(Butane-1,4-diylbis(oxy))dianiline
Similarity: 0.88
[ 917483-71-7 ]
4-(Tetrahydropyran-4-yloxy)aniline
Similarity: 0.93
[ 6245-50-7 ]
4,4'-(Butane-1,4-diylbis(oxy))dianiline
Similarity: 0.88